<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 22 May 2026 02:08:47 -0400--><rss version="2.0">
    <channel>
        <title>Kiora Pharmaceuticals, Inc. (KPRX) SEC Filings</title>
        <link>https://ir.kiorapharma.com/sec-filings/all-sec-filings/rss</link>
        <description>Kiora Pharmaceuticals, Inc. (KPRX) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_97e3629f093b7a3eb5d068243dee1637/kiorapharma/files/theme/images/logo-sm.png</url>
                <title>Kiora Pharmaceuticals, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[S-3 - Registration statement under Securities Act of 1933]]></title>
                <description><![CDATA[4 Related Documents: S-3, EX-FILING FEES, EX-5.1, EX-23.1]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000050/0001372514-26-000050.pdf</link>
                <pubDate>Mon, 18 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000050/0001372514-26-000050.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001104659-26-062696/0001104659-26-062696.pdf</link>
                <pubDate>Fri, 15 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001104659-26-062696/0001104659-26-062696.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001172661-26-002365/0001172661-26-002365.pdf</link>
                <pubDate>Fri, 15 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001172661-26-002365/0001172661-26-002365.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001104659-26-062628/0001104659-26-062628.pdf</link>
                <pubDate>Fri, 15 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001104659-26-062628/0001104659-26-062628.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000048/0001372514-26-000048.pdf</link>
                <pubDate>Fri, 08 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000048/0001372514-26-000048.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000047/0001372514-26-000047.pdf</link>
                <pubDate>Fri, 08 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000047/0001372514-26-000047.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000043/0001372514-26-000043.pdf</link>
                <pubDate>Fri, 01 May 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000043/0001372514-26-000043.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000040/0001372514-26-000040.pdf</link>
                <pubDate>Thu, 30 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000040/0001372514-26-000040.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[D - Notice of Exempt Offering of Securities]]></title>
                <description><![CDATA[D]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000038/0001372514-26-000038.pdf</link>
                <pubDate>Tue, 21 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000038/0001372514-26-000038.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[7 Related Documents: 8-K, EX-4.1, EX-4.2, EX-4.3, EX-10.1, EX-10.2, EX-99.1]]></description>
                <link>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000036/0001372514-26-000036.pdf</link>
                <pubDate>Tue, 07 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.kiorapharma.comhttps://ir.kiorapharma.com/sec-filings/all-sec-filings/content/0001372514-26-000036/0001372514-26-000036.pdf</guid>
                                                                            </item>
            </channel>
</rss>